| __timestamp | Dr. Reddy's Laboratories Limited | Merck & Co., Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 11606000000 |
| Thursday, January 1, 2015 | 42585000000 | 10313000000 |
| Friday, January 1, 2016 | 45702000000 | 9762000000 |
| Sunday, January 1, 2017 | 46372000000 | 9830000000 |
| Monday, January 1, 2018 | 46910000000 | 10102000000 |
| Tuesday, January 1, 2019 | 48890000000 | 10615000000 |
| Wednesday, January 1, 2020 | 50129000000 | 8955000000 |
| Friday, January 1, 2021 | 54559000000 | 9634000000 |
| Saturday, January 1, 2022 | 62081000000 | 10042000000 |
| Sunday, January 1, 2023 | 105931000000 | 10504000000 |
| Monday, January 1, 2024 | 77201000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, operational efficiency is key to maintaining a competitive edge. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two industry giants: Merck & Co., Inc. and Dr. Reddy's Laboratories Limited, from 2014 to 2023.
Dr. Reddy's Laboratories has shown a remarkable increase in SG&A expenses, growing by approximately 173% over the decade. In contrast, Merck & Co., Inc. maintained a relatively stable expenditure, with a slight increase of around 17%. Notably, Dr. Reddy's expenses surged in 2023, reaching a peak that was nearly ten times that of Merck's.
This disparity highlights differing strategic approaches, with Dr. Reddy's potentially investing more in market expansion and operational capabilities. However, the absence of data for Merck in 2024 suggests a need for cautious interpretation of recent trends.
Johnson & Johnson and Merck & Co., Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Merck & Co., Inc. vs AstraZeneca PLC Trends and Insights
Comparing SG&A Expenses: Merck & Co., Inc. vs Takeda Pharmaceutical Company Limited Trends and Insights
Breaking Down SG&A Expenses: Merck & Co., Inc. vs Verona Pharma plc
SG&A Efficiency Analysis: Comparing Merck & Co., Inc. and CymaBay Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Viking Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Celldex Therapeutics, Inc.
Comparing SG&A Expenses: Merck & Co., Inc. vs Xencor, Inc. Trends and Insights
Takeda Pharmaceutical Company Limited or Dr. Reddy's Laboratories Limited: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Dr. Reddy's Laboratories Limited or Ascendis Pharma A/S
Dr. Reddy's Laboratories Limited or Rhythm Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?